Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2016 | 1 |
2017 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
N Engl J Med. 2017 Jan 19;376(3):209-220. doi: 10.1056/NEJMoa1606468. Epub 2016 Dec 21.
N Engl J Med. 2017.
PMID: 28002688
Free article.
Clinical Trial.
Oral Cladribine in Patients who Change From First-Line Disease Modifying Treatments for Multiple Sclerosis: Protocol of a Prospective Effectiveness and Safety Study (CLAD CROSS).
Tsivgoulis G, Deftereos S, Gobbi C, Gulowsen Celius E, Kulakowska A, Maniscalco G, Mendes I, Grigoriadis N.
Tsivgoulis G, et al. Among authors: gulowsen celius e.
J Cent Nerv Syst Dis. 2022 Apr 1;14:11795735211069441. doi: 10.1177/11795735211069441. eCollection 2022.
J Cent Nerv Syst Dis. 2022.
PMID: 35392050
Free PMC article.
Item in Clipboard
A gene pathway analysis highlights the role of cellular adhesion molecules in multiple sclerosis susceptibility.
Damotte V, Guillot-Noel L, Patsopoulos NA, Madireddy L, El Behi M; International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2; De Jager PL, Baranzini SE, Cournu-Rebeix I, Fontaine B.
Damotte V, et al.
Genes Immun. 2014 Mar;15(2):126-32. doi: 10.1038/gene.2013.70. Epub 2014 Jan 16.
Genes Immun. 2014.
PMID: 24430173
Free article.
Item in Clipboard
Cite
Cite